According to the British Financial Times: Germany has clashed with other EU countries on the reform of pharmaceutical regulations, and the German government has warned that this will hurt investment in the pharmaceutical industry. Drugmakers are concerned that the European Union will cut exclusivity protection from 10 years to eight years.
According to the New York Times: A U.S. judge dismissed a lawsuit brought by